Muconasal Spray (Tramazoline Hydrochloride Monohydrate)

Tramazoline hydrochloride is an alpha‑adrenergic agonist used to relieve nasal congestion associated with various upper‑respiratory conditions.

• Nasal congestion: reduces swelling of the nasal mucosa and improves airflow.
• Acute rhinitis: alleviates blockage caused by inflammation of the nasal passages.
• Seasonal allergic rhinitis: provides temporary relief of nasal stuffiness during allergen exposure.

• Tramazoline hydrochloride acts as a selective alpha‑adrenergic receptor agonist on the vascular smooth muscle of the nasal mucosa. Stimulation of these receptors induces vasoconstriction, which decreases blood flow, reduces mucosal edema, and opens the nasal airway, thereby relieving congestion.

Common Side Effects

• Nasal dryness: mild irritation or crusting inside the nostrils.
• Sneezing: transient increase in sneezing episodes after administration.
• Epistaxis: occasional nosebleeds, usually mild.
• Headache: brief headache following use.
• Taste disturbance: altered sense of taste or metallic taste.
• Local irritation: burning or stinging sensation.

Serious or Rare Side Effects

• Hypertension: elevated blood pressure, especially with overuse.
• Tachycardia: rapid heart rate that may require monitoring.
• Arrhythmia: irregular heart rhythms in susceptible individuals.
• Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.
• Rebound congestion: worsening nasal blockage after prolonged use (rhinitis medicamentosa).

Before using Muconasal, consider the following precautions:

• Children under 6 years: avoid use unless directed by a healthcare professional.
• Prolonged use: limit to no more than three consecutive days to prevent rebound congestion.
• Hypertension: monitor blood pressure closely if you have high blood pressure.
• Cardiovascular disease: use with caution in patients with heart disease or arrhythmias.
• Pregnancy and lactation: safety not established; consult a physician before use.
• Store at room temperature: keep in the original container, protect from moisture and direct heat.

Tramazoline may interact with other medicines as follows:

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may cause excessive vasoconstriction and hypertensive crisis.
• Other sympathomimetic agents (e.g., phenylephrine): additive vasoconstrictive effects can increase cardiovascular risk.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask tachycardia caused by the nasal spray.
• Antihypertensive drugs: monitor blood pressure for potential elevation.
• Combination nasal decongestants: avoid using multiple decongestants simultaneously to reduce risk of systemic side effects.